Ticker > Company >

Mukka Proteins share price

Mukka Proteins Ltd.

  1.14 L   141   22 NSE: MUKKA BSE: 544135 SECTOR: Animal Feed

28.15
+1.31 (4.88%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 28.18

Today's Low

₹ 26.1

52 Week High

₹ 33.24

52 Week Low

₹ 18.32

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

844.5 Cr.

Enterprise Value

1466.43 Cr.

No. of Shares

30 Cr.

P/E

14.22

P/B

1.81

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  15.56

CASH

48.06 Cr.

DEBT

669.99 Cr.

Promoter Holding

73.33 %

EPS (TTM)

₹  1.98

Sales Growth

38.62%

ROE

9.96 %

ROCE

11.22%

Profit Growth

1.75 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year38.62%
3 Year4.85%
5 Year18.05%

Profit Growth

1 Year1.75%
3 Year2.47%
5 Year55.86%

ROE%

1 Year9.96%
3 Year15.53%
5 Year22.51%

ROCE %

1 Year11.22%
3 Year13.67%
5 Year16.3%

Debt/Equity

1.4979

Price to Cash Flow

-5.25

Interest Cover Ratio

2.1777

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 73.33 0.00
Mar 2026 73.33 0.00
Dec 2025 73.33 0.00
Sep 2025 73.33 0.00
Jun 2025 73.33 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 73.33%.

 Limitations

  • The company has shown a poor profit growth of 2.46597909677313% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.84992554432628% for the Past 3 years.
  • Company has negative cash flow from operations of -160.995.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 135.79 222.27 558.26 312.88 405.86
Total Expenditure 125.13 208.35 525.61 283.76 364.02
Operating Profit 10.66 13.93 32.66 29.12 41.84
Other Income 2.84 5.67 5.68 13.79 2.3
Interest 10.35 12.08 13.73 13.74 14.67
Depreciation 1.36 1.5 1.53 2.56 1.97
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.8 6.02 23.07 26.61 27.5
Tax 0.66 2.2 5.81 7.7 8.09
Profit After Tax 1.14 3.82 17.26 18.91 19.41
Adjusted EPS (Rs) 0.04 0.13 0.58 0.63 0.65

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 692.89 1066.4 1268.54 886.74 1229.21
Total Expenditure 660.37 1000.73 1187.16 810.63 1142.85
Operating Profit 32.52 65.67 81.39 76.12 86.36
Other Income 7.74 8.87 16.87 16.65 29.27
Interest 8.35 15.18 24.19 34.33 49.91
Depreciation 3.72 4.27 5.62 5.86 6.94
Exceptional Items 0 0 0 0 0
Profit Before Tax 28.2 55.1 71.65 52.58 58.78
Tax 8.38 15.67 8.89 10.9 16.37
Net Profit 19.82 39.42 62.76 41.68 42.41
Adjusted EPS (Rs.) 0.9 1.79 2.09 1.39 1.41

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 22 22 30 30 30
Total Reserves 60.29 99.64 335.17 374.37 417.3
Borrowings 3.04 0.27 3.32 1.29 6.07
Other N/C liabilities 6.25 9.46 7.4 6.56 14.41
Current liabilities 237.5 368.67 475.24 561.79 900.61
Total Liabilities 329.07 500.03 851.13 974 1368.39
Assets
Net Block 48.3 51.08 58.46 58.24 87.1
Capital WIP 0 0 0 3.8 0.37
Intangible WIP 0 0 0 0 0.17
Investments 20.67 23.63 34.38 43.8 71.03
Loans & Advances 1.97 3.33 7.11 10.35 31.46
Other N/C Assets 1.38 1.59 1.48 1.38 18.02
Current Assets 256.75 420.4 749.71 856.42 1160.25
Total Assets 329.07 500.03 851.13 974 1368.39
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 28.2 55.1 71.65 52.58 58.78
Adjustment 5.05 7.71 14.98 22.42 49.36
Changes in Assets & Liabilities -46.21 -101.08 -205.29 -204.75 -256.5
Tax Paid -2.34 -8.68 -22.58 -2.62 -12.63
Operating Cash Flow -15.3 -46.96 -141.24 -132.38 -161
Investing Cash Flow -7.25 0.71 -46.25 -18.02 -42.73
Financing Cash Flow 27.25 61.12 258.05 59.65 205.22
Net Cash Flow 4.7 14.87 70.57 -90.74 1.5

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2026

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26

Company News

Mukka Proteins Stock Price Analysis and Quick Research Report. Is Mukka Proteins an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mukka Proteins. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mukka Proteins has a PE ratio of 13.6010101010101 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mukka Proteins has ROA of 3.6213% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mukka Proteins has a Current ratio of 1.2883.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mukka Proteins has a ROE of 9.9598%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Mukka Proteins has a Debt to Equity ratio of 1.4979 which means that the company has low proportion of debt in its capital.

  • Sales growth: Mukka Proteins has reported revenue growth of 38.6202% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Mukka Proteins for the current financial year is 7.02567919915717%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mukka Proteins is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mukka Proteins is Rs 1.98. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mukka Proteins in Ticker for free. Also, one can get the intrinsic value of Mukka Proteins by using Valuation Calculators, which are available with a Finology ONE subscription. 

Mukka Proteins FAQs

Q1. What is Mukka Proteins share price today?
Ans: The current share price of Mukka Proteins is Rs 26.93.

Q2. What is the market capitalisation of Mukka Proteins?
Ans: Mukka Proteins has a market capitalisation of Rs 807.9 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Mukka Proteins?
Ans: The PE ratio of Mukka Proteins is 13.6010101010101 and the P/B ratio of Mukka Proteins is 1.73106467226761, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Mukka Proteins share?
Ans: The 52-week high share price of Mukka Proteins is Rs 33.22, and the 52-week low share price of Mukka Proteins is Rs 18.27.

Q5. Does Mukka Proteins pay dividends?
Ans: Currently, Mukka Proteins does not pay dividends. Dividend yield of Mukka Proteins is around 0%.

Q6. What are the face value and book value of Mukka Proteins shares?
Ans: The face value of Mukka Proteins shares is Rs 1, while the book value per share of Mukka Proteins is around Rs 15.5569. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Mukka Proteins?
Ans: Mukka Proteins has a total debt of Rs 669.987 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Mukka Proteins?
Ans: The ROE of Mukka Proteins is 9.9598% and ROCE of Mukka Proteins is 11.2239%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Mukka Proteins a good buy for the long term?
Ans: The Mukka Proteins long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Mukka Proteins undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Mukka Proteins appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Mukka Proteins’s financials?
Ans: You can review Mukka Proteins’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Mukka Proteins
X